World of DTC Marketing

JUNE 6, 2025

With reports of budget constraints and layoffs hitting federal agencies like the FDA and CDC, many talented public health professionals are suddenly finding themselves out of work. As they look to the private sector—particularly the pharmaceutical and biotech industries—the question arises: do they possess the right business skills to make a successful transition ?

Compliance 244

Compliance Marketing Life Science Production 244

Bio Pharma Dive

JUNE 1, 2025

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of initial treatment, potentially opening a novel step in patient care.

Drugs 279

Drugs 279

Pharmaceutical Technology

JUNE 2, 2025

BMS and BioNTech will jointly develop and commercialise the asset that targets both PD-L1 and VEGF-A.

Development 221

Development Drugs 221

STAT News

JUNE 5, 2025

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in people taking the powerful medications. The research, published Thursday in JAMA Ophthalmology , found that after one year, more than twice as many people on GLP-1 drugs developed neovascular age-related macular degeneration compared to similar people who were no

Drugs 118

Drugs Development Research 118

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.

Compliance

World of DTC Marketing

JUNE 3, 2025

In the pharma industry, it’s almost reflexive to tap an MD for the role of Vice President of Medical Affairs. After all, Medical Affairs serves as the bridge between clinical research, regulatory compliance, marketing, and real-world evidence — all areas where deep medical knowledge is a valuable asset. But here’s the truth few want to say out loud: appointing an MD as head of Medical Affairs isn’t always the best move.

Compliance 197

Compliance Doctor Doctors Marketing 197

Bio Pharma Dive

JUNE 2, 2025

The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD1 and VEGF, following Merck, and Pfizer into what’s become a competitive development race.

Drugs 293

Drugs Protein Development 293

Rethinking Clinical Trials

JUNE 3, 2025

Dr. Margaret Kuklinski and Dr. Stacy Sterling, coprincipal investigators for GGC4H In an evaluation conducted alongside the GGC4H trial, researchers assessed the intervention fidelity of a version of the Guiding Good Choices parenting program that was adapted for online delivery. They found that virtual delivery of the intervention was feasible but that retention of participants was a challenge.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

World of DTC Marketing

MAY 31, 2025

Each year, the American Society of Clinical Oncology (ASCO) meeting brings together the brightest minds in cancer research, pharmaceuticals, and patient care to share breakthroughs, data, and hope. And each year, one glaring topic remains conspicuously under-discussed: the brutal, life-altering cost of cancer treatment. We celebrate new therapies. We hear about remarkable survival data.

Drugs 197

Drugs Nurses Doctor Doctors 197

Bio Pharma Dive

MAY 31, 2025

AstraZeneca and Daiichi Sankyo’s drug extended survival by 30% compared to a widely used regimen, further establishing its importance as a second-line treatment option.

Drugs 239

Drugs 239

Pharmaceutical Technology

JUNE 2, 2025

Sanofi has signed an agreement to acquire US-based Blueprint Medicines to bolster its immunology pipeline with rare disease treatments.

Medicine 162

Medicine 162

Advertisement

Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness

Trials

Scienmag

JUNE 6, 2025

In the rapidly evolving landscape of healthcare education, Massive Open Online Courses (MOOCs) have emerged as pivotal tools, particularly during the global challenges imposed by the COVID-19 pandemic. A recent comprehensive study sheds light on the acceptance, effectiveness, and transformative potential of MOOCs designed specifically for healthcare professionals engaged in lifelong learning.

Development 104

Development Regulation Research Medicine 104

World of DTC Marketing

JUNE 3, 2025

It’s easy to get swept up in the hype of the latest miracle drug. Right now, that miracle is Ozempic. Originally developed to treat type 2 diabetes, it’s now making headlines—and billions—for its off-label use in weight loss. Celebrities endorse it. Social media glorifies it. And suddenly, everyone wants a prescription. But here’s the truth: Ozempic is not for everyone.

Doctor 201

Doctor Doctors Insulin Pharmacy 201

Bio Pharma Dive

JUNE 5, 2025

A deal worth up to $712 million with the China-based biotech gives Cullinan T cell engagers aimed at BCMA and CD19, two targets of interest in inflammatory conditions.

236

236

Pharmaceutical Technology

JUNE 6, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Drugs 130

Drugs Clinical Trials Clinical Trials Life Science 130

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Rethinking Clinical Trials

JUNE 6, 2025

May 28-29, 2025 | Bethesda, MD Main Purpose Day 1 : Hear from the newest and sunsetting NIH Collaboratory Trials; share challenges and lessons learned to promote successful trial conduct; discuss considerations for future embedded pragmatic clinical trials (ePCTs) such as understanding decision-maker perspectives and improving implementation of ePCT findings.

Trials 100

Trials Clinical Trials Clinical Trials Research 100

World of DTC Marketing

JUNE 4, 2025

In 2025, the cost of employer-sponsored health insurance for a family of four has surged past $35,000 annually. That’s nearly triple the cost from just two decades ago. While wages have grown at a modest pace over the same period, healthcare costs have skyrocketed—leaving families, employers, and our healthcare system struggling to cope under the pressure.

Packaging 174

Packaging Packaging Production Marketing 174

Bio Pharma Dive

JUNE 3, 2025

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

Drugs 216

Drugs 216

Pharmaceutical Technology

JUNE 3, 2025

First-in-human data for the trispecific antibody suggest a paradigm shift for the relapsed/refractory multiple myeloma space.

Antibody 130

Antibody 130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

STAT News

JUNE 5, 2025

In the late 2010s, scientists at the Danish drugmaker Novo Nordisk developed a new weekly obesity treatment that targeted three hormones at once. In mice studies , the drug, which activated receptors of the GLP-1, GIP, and glucagon hormones, caused notable weight loss. But Novo shelved the therapy. The company was concerned about potential side effects of targeting glucagon, like increasing blood sugar and heart rate.

Drugs 115

Drugs Hormones Branding Development 115

Medical Xpress

JUNE 6, 2025

In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for more tools for their arsenal.

Vaccination 105

Vaccination Vaccine Scientist 105

Bio Pharma Dive

JUNE 4, 2025

Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a competitive field. Hiroyuki Okuzawa is working to keep it that way.

Drugs 202

Drugs Antibody Development 202

Pharmaceutical Technology

JUNE 3, 2025

SpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform.

Drug Delivery 130

Drug Delivery Drugs 130

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?

Compliance

Rethinking Clinical Trials

JUNE 5, 2025

The Health Care Systems Research Network (HCSRN) will hold its 2026 Annual Conference from April 21 to 23, 2025, in Dallas, Texas. HCSRN is a 20-member research network focused on supporting research institutes aligned with healthcare delivery systems. HCSRNs mission is to improve individual and population health through research that connects the resources and capabilities of learning healthcare systems.

Clinical Trials 130

Clinical Trials Clinical Trials Research Trials 130

Medical Xpress

JUNE 6, 2025

A new study published in JAMA Psychiatry makes the case that symptom provocation may significantly improve the clinical effectiveness of repetitive transcranial magnetic stimulation (rTMS), a noninvasive brain stimulation method used to treat depression, obsessive-compulsive disorder (OCD) and nicotine dependence.

97

97

Bio Pharma Dive

JUNE 4, 2025

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene therapy applications it later brings to the regulator.

Gene Therapy 201

Gene Therapy Gene Regulation 201

Pharmaceutical Technology

JUNE 3, 2025

The FDA set a PDUFA date in late 2025 as ziftomenib led to significant disease response in patients with common subtype of AML.

130

130

Advertisement

Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.

Life Science

Scienmag

JUNE 5, 2025

A groundbreaking study emerging from the research laboratories of Mass General Brigham has revealed compelling connections between brain health and systemic diseases that extend far beyond neurological disorders. The recent findings, published in the journal Family Practice , demonstrate that individuals with higher scores on the McCance Brain Care Score (BCS) display not only a reduced risk of brain-related conditions such as stroke, dementia, and depression but also a markedly lower likelihood

Biobanking 94

Biobanking Research Cardiology Medicine 94

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 4, 2025

Indian healthcare sector is increasingly driven by a digitally enabled and globally competent workforce, positioning the sector to meet both domestic needs and international standard. The sector is undergoing a transformative shift. This evolution supports improved patient outcomes, strengthens global collaborations, and enhances Indias position in international healthcare delivery and innovation.

Clinical Trials 110

Clinical Trials Clinical Trials Trials 110

Bio Pharma Dive

JUNE 4, 2025

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best to use new bispecific antibodies, and expressed concern about looming cuts to science funding.

Doctor 185

Doctor Doctors Antibody Drugs 185

Pharmaceutical Technology

JUNE 6, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Clinical Trials 130

Clinical Trials Clinical Trials Manufacturing Trials 130

Advertisement

Clinical Supply